Carpal Tunnel Syndrome in Hemodialyzed Patients

Bordoni, E.; Gaffi, G.; Mioli, V

doi:10.1177/039139888901201214

Cited by 3 publications

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some clinical studies have indicated that the prevalence of dialysis amyloidosis may depend on the dialy sis membrane used. In these studies, the prevalence of amyl oidosis has been found to be higher in patients dialyzed with standard cuprophane membranes than in those treated with the more biocompatible polyacrylonitrile AN 69 membranes [3][4][5][6], Other investigators have not been able to confirm these findings, however [7,8],…”

Section: Introductionmentioning

confidence: 99%

Radiolucent Bone Cysts and the Type of Dialysis Membrane Used in Patients Undergoing Long-Term Hemodialysis

Miura¹,

Ishiyama²,

Inomata³

et al. 1992

Nephron

View full text Add to dashboard Cite

The relationship between the types of dialysis membrane used and the prevalence and severity of radiolucent bone cysts (which are a main radiological feature of dialysis amyloidosis) was studied in 30 patients on hemodialysis for more than 10 years. One of them was treated exclusively with cuprophane; the other 29 were dialyzed with cuprophane, and then treated with polyacrylonitrile AN 69. In 12 of the 30 patients, radiolucent bone cysts (at least 5 mm in diameter in the wrists and at least 10 mm in the shoulders or hips) were observed. The patients with bone cysts spent significantly more time on cuprophane dialysis and significantly less time on AN 69 dialysis than the group of patients without bone cysts. Nine of the 14 patients who had been treated with cuprophane for more than 8 years had bone cysts; whereas bone cysts were observed in only 2 of the 12 patients dialyzed for more than 8 years with AN 69. The frequency of bone cysts was significantly different for each of the two groups. There was, however, no significant difference in the total duration of dialysis between the two groups. The severity of the cystic bone lesions correlated positively with the duration of dialysis using cuprophane and negatively with the duration of dialysis using AN 69. These findings suggest that the development of osteoarticular amyloidosis may be related to the type of dialysis membrane used. Hemodialysis using AN 69 membranes may prevent, or at least postpone the development of dialysis amyloidosis.

show abstract

Section: Introductionmentioning

confidence: 99%

Radiolucent Bone Cysts and the Type of Dialysis Membrane Used in Patients Undergoing Long-Term Hemodialysis

Miura¹,

Ishiyama²,

Inomata³

et al. 1992

Nephron

View full text Add to dashboard Cite

show abstract

ReadiGraft BLX Putty and ReadiGraft Bone Chips in the Treatment of Severe Osteoarthropathy in Hemodialysed Patient.

2020

scmcrj

View full text Add to dashboard Cite

Abstract Osteoarticular complications are a major concern in patients treated with long-term hemodialysis, hemofiltration or continuous ambulatory peritoneal dialysis. Uremic chronic patients, treated for long periods of time (≥15 years) with hemodialysis, could develop a new kind of osteoarthropathy due to amyloidosis characterized by abnormal distribution of beta-2 microglobulin (B2M) in joint tissue. Deposits of B2M are responsible for several lesions, clinically evident in different pathologies, such as: carpal tunnel syndrome, spondylarthrosis, and hemodialysis osteoarthropathy.

show abstract

ReadiGraft BLX Putty and ReadiGraft Bone Chips in the Treatment of Severe Osteoarthropathy in Hemodialysed Patient.

2020

scmcrj

View full text Add to dashboard Cite

Osteoarticular complications are a major concern in patients treated with long-term hemodialysis, hemofiltration or continuous ambulatory peritoneal dialysis. Uremic chronic patients, treated for long periods of time (≥15 years) with hemodialysis, could develop a new kind of osteoarthropathy due to amyloidosis characterized by abnormal distribution of beta-2 microglobulin (B2M) in joint tissue. Deposits of B2M are responsible for several lesions, clinically evident in different pathologies, such as: carpal tunnel syndrome, spondylarthrosis, and hemodialysis osteoarthropathy.

show abstract

Carpal Tunnel Syndrome in Hemodialyzed Patients

Cited by 3 publications

References 2 publications

Radiolucent Bone Cysts and the Type of Dialysis Membrane Used in Patients Undergoing Long-Term Hemodialysis

Radiolucent Bone Cysts and the Type of Dialysis Membrane Used in Patients Undergoing Long-Term Hemodialysis

ReadiGraft BLX Putty and ReadiGraft Bone Chips in the Treatment of Severe Osteoarthropathy in Hemodialysed Patient.

ReadiGraft BLX Putty and ReadiGraft Bone Chips in the Treatment of Severe Osteoarthropathy in Hemodialysed Patient.

Contact Info

Product

Resources

About